Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Vivet Therapeutics has raised $5.3M in total funding. The most recent round was Grant. The last funding was announced in February 2024.
Vivet Therapeutics's investors include Pfizer, Kurma Partners, Eurazeo, HealthCap, Columbus Venture Partners.
Vivet Therapeutics is headquartered in Paris, France.
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Vivet Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vivet Therapeutics — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/vivet-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Vivet Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vivet-therapeutics
{{cite web |title=Vivet Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivet-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated